Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90. Following the transaction, the chief executive officer directly owned 175,401 shares in the company, valued at approximately $5,095,399.05. This represents a 0.55% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Margaret Tooth also recently made the following trade(s):
- On Monday, May 25th, Margaret Tooth sold 491 shares of Trupanion stock. The shares were sold at an average price of $21.86, for a total transaction of $10,733.26.
Trupanion Stock Performance
Shares of TRUP traded up $0.68 during mid-day trading on Thursday, hitting $31.00. 541,432 shares of the company’s stock were exchanged, compared to its average volume of 440,807. Trupanion, Inc. has a 52 week low of $21.16 and a 52 week high of $50.06. The stock’s 50-day simple moving average is $25.20 and its 200-day simple moving average is $26.09. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 58.49, a price-to-earnings-growth ratio of 2.23 and a beta of 1.39. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24.
Analyst Ratings Changes
Several analysts recently weighed in on the company. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. Stifel Nicolaus set a $28.00 price target on shares of Trupanion in a research note on Friday, June 26th. Atlantic Securities set a $42.00 price target on Trupanion in a research note on Wednesday, July 15th. Finally, Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Trupanion has an average rating of “Moderate Buy” and a consensus target price of $41.60.
Get Our Latest Report on Trupanion
Institutional Investors Weigh In On Trupanion
A number of hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP grew its holdings in shares of Trupanion by 15.7% during the first quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider’s stock valued at $17,981,000 after buying an additional 95,064 shares during the last quarter. Polar Capital Holdings Plc lifted its position in Trupanion by 13.5% in the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock valued at $55,121,000 after acquiring an additional 175,000 shares in the last quarter. Kopion Asset Management LLC boosted its stake in Trupanion by 30.9% during the 2nd quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider’s stock valued at $12,955,000 after purchasing an additional 123,308 shares during the last quarter. Hosking Partners LLP boosted its stake in Trupanion by 8.1% during the 4th quarter. Hosking Partners LLP now owns 465,950 shares of the financial services provider’s stock valued at $17,413,000 after purchasing an additional 35,020 shares during the last quarter. Finally, R Squared Ltd increased its holdings in Trupanion by 44.7% during the 4th quarter. R Squared Ltd now owns 9,075 shares of the financial services provider’s stock worth $339,000 after purchasing an additional 2,803 shares in the last quarter.
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
See Also
- Five stocks we like better than Trupanion
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
